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Endothelial-to-mesenchymal transitionVascular dysfunction, characterized by the endothelial-to-mesenchymal transition (EndMT), contributes to the de-
velopment of cardiac ﬁbrosis induced by pressure overload. Toll-like receptor (TLR)5 is a member of the TLR family
that is expressed on not only immune cells but also nonimmune cells including cardiomyocytes and vascular endo-
thelial cells. The level of TLR5 expression on endothelial cells is low under normal circumstances but is increased in
response to stimuli such as pressure overload. The aim of this study was to investigate the importance of TLR5 in
cardiac endothelial dysfunction during the development of cardiac ﬁbrosis induced by pressure overload. Global
TLR5-deﬁcientmice andwild-type littermates underwent aortic banding (AB) for 8weeks to induce cardiacﬁbrosis,
hypertrophy and dysfunction. The deﬁciency of TLR5 in this model exerted no basal effects but attenuated the car-
diac ﬁbrosis, hypertrophy and dysfunction induced by pressure overload. AB-induced endothelial TLR5 activation
enhanced the development of cardiacﬁbrosis independent of cardiomyocyte hypertrophy and triggered left ventric-
ular dysfunction. TLR5-deﬁcientmice also exhibited amelioratedmyocardial pro-inﬂammatory cytokine expression
andmacrophage inﬁltration and inhibited the EndMT, all ofwhich contribute to the development of cardiac ﬁbrosis.
These ﬁndings suggest that TLR5 triggers inﬂammatory responses and promotes the EndMT, whichmay be an impor-
tantmechanismunderlying the promotion of cardiacﬁbrosis and left ventricular dysfunction during pressure overload.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Endothelial cells have a profound effect on cardiac function; many
studies have demonstrated the involvement of endothelial–cardiomyo-
cyte crosstalk in the pathogenesis of adverse cardiac remodelling [1–4].
Zeisberg et al. [5] discovered that cardiac ﬁbrosis induced by aortic
banding (AB) is associated with the emergence of ﬁbroblasts originating
from endothelial cells, suggesting a mechanism of endothelial–mesen-
chymal transition (EndMT).
Over the past few years, more and more studies have indicated the
causative contribution of the immune system in hypertrophy and heart
failure [6,7]. Neurohumoral activation especially the release of angioten-
sin II (Ang II) during pressure overload might activate innate immune
mechanisms and trigger a potent inﬂammatory reaction that ultimately
results in cardiac hypertrophy and reparative ﬁbrosis, leading to cardiac
dysfunction [8,9]. Therefore, inhibiting inﬂammation and improving endo-
thelial function may serve as potential therapeutic strategies for the treat-
ment of cardiac remodelling.y, Renmin Hospital of WuhanTLR5 is expressed on not only immune cells (monocytes/macro-
phages and immature dendritic cells) but also nonimmune cells includ-
ing cardiomyocytes and vascular endothelial cells [10]. Previous
research has indicated that TLR5 can trigger cardiac innate immune re-
sponses and cause acute contractile dysfunction when combined with
its ligand ﬂagellin [11]. However, the role of TLR5 in pressure
overload-induced cardiac remodelling has yet to be elucidated. Here,
we used TLR5 gene-deﬁcient mice to investigate the exact role of TLR5
in the development of cardiac remodelling induced by pressure over-
load. For the ﬁrst time, we demonstrated that TLR5 deﬁciency in mice
attenuates the cardiac ﬁbrosis, hypertrophy and dysfunction induced
by pressure overload via the inhibition of inﬂammation and the
endothelial-to-mesenchymal transition (EndMT), indicating a crucial
role of TLR5 in regulating cardiac remodelling.2. Materials and methods
2.1. Animals and animal models
All of the studies were performed in accordance with the Guide for
the Care and Use of Laboratory Animals published by the US National
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approved by the Animal Care and Use Committee of Renmin Hospital of
Wuhan University (protocol number: 00013274). TLR5 KO mice (C57
background, purchased from Jackson Laboratory) and their wild-type
(WT) littermateswere used in our studies andwere divided into the fol-
lowing four groups: (1) WT littermates subjected to sham operation,
(2) TLR5 KOmice subjected to sham operation, (3)WT littermates sub-
jected to aortic banding (AB), and (4) TLR5 KOmice subjected to AB. AB
was performed as described previously [12–14]; all of the mice used in
our studies were 8–10-week-old males with a body weight of 23.5–
27.5 g. 8 weeks following AB, the body weight, heart weight, lung
weight and tibial length (TL) of the mice were measured to compare
the heart weight/body weight (HW/BW, mg/g), lung weight/body
weight (LW/BW, mg/g), and heart weight/TL (HW/TL, mg/mm) ratios.
2.2. Echocardiographic analyses
The internal diameter and the wall thickness of the left ventricle
were assessed via echocardiography and were performed on anaesthe-
tized (1.5% isoﬂurane) mice using a MyLab 30CV ultrasound (ESAOTE
S.p.A) equipped with a 10-MHz linear array ultrasound transducer.
The left ventricle (LV) dimensions were assessed in the parasternal
short-axis view. End-systole and end-diastole were deﬁned as the
phase during which the smallest and the largest area of the LV was ob-
tained, respectively.
2.3. Quantitative real-time RT-PCR
Total RNA was extracted from frozen mouse cardiac tissue, human
umbilical vein endothelial cells (HUVEC-12), or cardiomyocytes using
TRIzol reagent (Invitrogen, 15596-026). The yield and the purity of
the RNA samples were spectrophotometrically estimated based on the
A260/A280 and A230/A260 ratios using a NANODROP 2000c (Thermo
Scientiﬁc). RNA (2 μg of each sample) was reverse-transcribed into
cDNA using oligo(dT) primers and the Transcriptor First Strand cDNA
Synthesis Kit (Roche, 04896866001). We then employed SYBR Green
PCR Master Mix (Roche, 04707516001) to quantify PCR ampliﬁcation
using a Light Cycler 480 instrument (Software version 1.5, Roche); the
results were normalized to GAPDH expression.
2.4. Western blot
Cardiac tissue, cultured H9c2 cardiomyoblasts and HUVEC-12 cells
were lysed in RIPA lysis buffer, and the protein concentrations were
measured using the BCAprotein assay kit (Thermo, 23227) and a Syner-
gy HT microplate reader. The cell lysates (50 μg) were fractionated via
10% SDS-PAGE. Then, the proteins were transferred to a PVDF mem-
brane (Millipore, Beijing, China) and incubated in speciﬁc antibodies
against different antigens, including p-Smad2 (Cell Signaling Technolo-
gy, CST, 3101), Smad2 (Santa Cruz, sc-6200), p-Smad3 (CST, 8769),
Smad3 (Santa Cruz, sc-101154), CD31 (ABCAM, ab28364), α-SMA
(ABCAM, ab7817), vimentin (Santa Cruz, sc-5565), and TLR5 (Santa
Cruz, sc-30003). Following incubation in a secondary IRDye® 800CW-
conjugated antibody for 60 min, the blots were scanned using a two-
colour infrared imaging system (Odyssey, LICOR) to quantify protein ex-
pression. The expression level of each target protein was normalized to
that of GAPDH (Santa Cruz, sc-25778) for the total cell protein lysates.
2.5. Histological analysis and immunoﬂuorescence
The hearts were excised, washed with PBS, arrested in diastole with
10% KCl, ﬁxed with 10% paraformaldehyde, and embedded in parafﬁn.
They were sectioned transversely near the apex to visualize the left
and the right ventricles. Several sections of each heart (5-μm thick)
were prepared, stainedwith haematoxylin & eosin (HE) for histopathol-
ogy or picrosirius red (PSR) for collagen deposition and visualized vialightmicroscopy; the captured imagesweremeasured using a quantita-
tive digital image analysis system (Image Pro-Plus, IPP, version 6.0).
The expression and the localization of different target genes were
observed using immunoﬂuorescence methods. The sections were
autoclaved for antigen retrieval, blockedwith 10% goat serum and incu-
bated in primary antibodies against CD68 (BD Serotec,MCA1957),WGA
(Invitrogen), CD31, α-SMA, and/or collagen III (Santa Cruz, sc-8781)
overnight at 4 °C, followed by incubation in two different IRDye®
800CW-conjugated antibodies for 60 min. The sections were subse-
quently mounted and coverslipped using SlowFade Gold antifade re-
agent containing 4′-6-diamidino-2-phenylindole (DAPI, Invitrogen,
S36939).
2.6. Cultured H9c2 cardiomyoblasts and neonatal rat cardiomyocytes
The rat cardiomyocyte-derived cell line H9c2was obtained from the
Cell Bank of the Chinese Academy of Sciences (Shanghai, China, GNR5).
The cells were cultured in basal DMEM (1×) (GIBCO, C11995) supple-
mented with 10% newborn calf serum (NCS, Hyclone, SH30560.01)
and 1% penicillin/streptomycin (PS, GIBCO 1308300) at 37 °C in a hu-
midiﬁed environment containing 5% CO2 (SANYO 18M). Before treat-
ment with angiotensin II (Ang II, Sigma, A9525, 1 μM) for 24 h, the
cells were cultured in basal DMEM (1×) supplemented with 0.2% NCS
and 0.05% PS for 18 h to eliminate the inﬂuence of NCS.
To examine the role of TLR5 acting during cardiac hypertrophy, H9c2
cells were cultured in 6-well plates at a density of 1 × 106 cells/well and
then transfected with a plasmid lower-expressing TLR5 (Ad-
TLR5shRNA, SANTA CRUZ, sc-270186-SH) using FuGENE®HD Transfec-
tion Reagent (Promega, E2311). TLR5 lower-expressing H9c2 cells were
obtained following a 24-hour incubation period in the presence of Ad-
TLR5shRNA. To assess cardiomyocyte hypertrophy, we characterized
the cells by analyzing their cardiacα-actinin expression using immuno-
ﬂuorescence. The cells were washed with PBS, ﬁxed with RCL2
(ALPHELYS, RCL2-CS24L), permeabilized in 0.1%Triton X-100 in PBS,
and stained with anti α-actinin (Millipore, 05-384) at a dilution of
1:100 in 1% goat serum. The secondary antibody was Alexa Fluor®
488 goat antimouse IgG (Invitrogen, A11004). The myocytes on cover-
slips were mounted onto glass slides with SlowFade Gold antifade re-
agent with DAPI.
The primary cultures of cardiomyocytes were prepared as described
previously [15]. Cells from the heart of 1 to 7-day-old Sprague-Dawley
rats (Wuhan University Center for Animal Experiments/A3-Lab) were
seeded at a density of 1 × 106 cells/well on 6-well culture plates in the
plating medium consisting of DMEM/F12 medium supplemented with
10% foetal bovine serum (FBS) and 1% PS. 48 h later, this medium was
replaced with DMEM/F12 medium supplemented with 0.2% FBS and
0.1 mM 5-bromo-2-deoxyuridine (BrdU, Sigma, B5002). The cells
were serum-starved for 12 h, followed by treatment with Ang II
(1 μM) for an additional 24 h.
2.7. Culture of HUVEC-12 cells
The HUVEC-12 cell line was purchased from YRGene (NC006). The
cells were cultured in collagen-coated dishes containing DMEM (1×)
medium supplemented with 10% FBS, heparin (0.1 mg/ml) and Endo-
thelial Cell Growth Supplement (ECGS, ScienCell, 1052, 10 μl/ml) at
37 °C in a humidiﬁed environment containing 5% CO2; the cells between
the fourth and sixth passages were used. The cells were treatedwith re-
combinant human TGF-β1 (PEPROTECH, 100-21C, 10 ng/ml), and the
medium was changed every 24 h for 3 consecutive days.
To examine the role of TLR5, we performed gain-of-function studies
using HUVEC-12 cells. Before TGF-β1 treatment, the HUVEC-12 cells
were transfected with a plasmid over-expressing TLR5 (Ad-TLR5,
Addgene, 13019) using FuGENE®HD Transfection Reagent (Promega,
E2311). TLR5-overexpressing HUVEC-12 cells were obtained following
a 24-hour incubation period in the presence of Ad-TLR5. The migration
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wound assay. The cells were seeded in 6-well collagen-coated plates
and treated with TGF-β1 for 3 consecutive days; then, the HUVEC-12
cells were serum-starved for 4 h. Scratch wounds were generated
using a 200-μl sterile pipette tip, and the cells were stimulated with
the basal medium. At 0, 6, 12 or 24 h after injury, migratory cells were
stainedwith 0.2% crystal violet and photographed using an invertedmi-
croscope (OLYMPUS, Japan).
2.8. Statistical analysis
All data were expressed as the means ± SEMs. Comparisons be-
tween two groups were performed using the unpaired Student's t test.
Differences between the groups were determined via one-way ANOVA
followed by a Student–Newman–Keuls (SNK) test. P b 0.05 indicates a
statistically signiﬁcant difference.
3. Results
3.1. Myocardial TLR5 gene expression increases following AB
To investigate the expression of TLR5 in themyocardium during car-
diac remodelling, we examined TLR5 expression via WB and real-time
RT-PCR at various time points after AB. Both the protein and mRNA
levels of TLR5 were signiﬁcantly increased 1 week after AB compared
with the sham operation; increased expression was also observed 4
and 8 weeks after AB, and a particularly high expression level was de-
tected 1 week after AB (Fig. 1a–c).
3.2. The gene expression of TLR5 in neonatal rat cardiac myocytes, H9c2
cardiomyoblasts and endothelial cells during experimental cardiac
remodelling
To explore the expression of TLR5 in different cell lines during exper-
imental cardiac remodelling, we used a cell culture model that allows
for neonatal rat cardiacmyocytes, H9c2 cardiomyoblasts and endotheli-
al cells to be evaluated separately. TLR5 was expressed in the above
three cell lines; however, no apparent change in the level of TLR5
mRNA in neonatal rat cardiomyocytes treated with Ang II or TGF-β1
was observed (Fig. 2a,b), as well as the level of TLR5 protein in the
H9c2 cardiomyoblasts treated with Ang II (Fig. 2c,d), although a hyper-
trophic response was evident. TGF-β1 is a potent promoter of the
EndMT in both human andmouse coronary endothelial cells; in our ex-
periment, both the mRNA (Fig. 2d) and protein (Fig. 2e,f) expression of
TLR5 were upregulated when the HUVEC-12 cells were treated with
10 ng/ml TGF-β1 for 3 consecutive days.Fig. 1. TLR5 expression in the myocardium after AB-induced pressure overload. Western blot (
indicated time points after AB (n = 6). *P b 0.05 vs sham.To further examine the role of TLR5 acting during cardiac hypertro-
phy, Ang II or TGFβ1 stimulation was provided for 24 h after TLR5 gene
was silenced by H9c2 cells transfected by Ad-TLR5shRNA (TLR5 lower-
expression was conﬁrmed via RT-PCR) (Fig. 2h), and it was found that
hypertrophy degree of cardiomyocytes was not signiﬁcantly different
from that in Ang II group andmRNA levels of molecular markers of car-
diomyocyte hypertrophy, and ANP and BNP, were also not signiﬁcant
(Fig. 2i). The results of α-actin also demonstrated that hypertrophy de-
gree of cardiomyocytes was not signiﬁcantly different fromAng II group
(Fig. 2j,k). The results above indicated that TLR5 may act in ventricular
reconstruction instead of cardiomyocytes.
3.3. TLR5 deﬁciency attenuates the cardiac hypertrophy and dysfunction in-
duced by pressure overload
TLR5-deﬁcient mice andWT littermate control mice were subjected
to either AB or sham surgery for 8weeks; theHW/BW, LW/BWandHW/
TL ratios and the cardiomyocyte cross-sectional areas (CSAs) were sig-
niﬁcantly decreased in the AB-treated TLR5-deﬁcient mice compared
to the AB-treatedWTmice, whereas no signiﬁcant differences between
the sham-operated mice were observed (Fig. 3a–d). The gross heart
characteristics and the HE and WGA staining results also conﬁrmed
the role of TLR5 deﬁciency in cardiac remodelling (Fig. 3e).
To investigate whether the absence of TLR5 inﬂuences AB-induced
cardiac dysfunction, echocardiography was performed to evaluate the
structure and the function of the LV, including the wall thickness, the
chamber diameter and indicators of left ventricular compliance. No sig-
niﬁcant difference in these parameters was detected between the
sham-operated TLR5-deﬁcient and WT mice. 8 weeks after AB, the
TLR5-deﬁcient mice demonstrated signiﬁcant attenuations in the LV
wall thickness; chamber dilation, myocardial compliance and
haemodynamics compared with the WT mice (Fig. 3f,g).
We also assessed the mRNA expression of cardiac remodelling
markers; our results revealed signiﬁcantly lower levels of ANP, BNP
and β-MHC and higher levels of α-MHC in the AB-induced TLR5-
deﬁcient mice than in the WT mice (Fig. 3h–k). These data indicated
that TLR5 deﬁciency is responsible for the attenuation of the cardiac re-
modelling induced by pressure overload.
3.4. Effects of TLR5 deﬁciency on the cardiac ﬁbrosis induced by pressure
overload
To investigate the degree of interstitial ﬁbrosis, parafﬁn-embedded
sections of the LVwere stainedwith PSR, revealing that AB-induced car-
diac ﬁbrosis (perivascular and interstitial) was signiﬁcantly attenuated
in the global TLR5 KO mice compared with the WT mice. There was noWB) analysis (a,b) and RT-PCR analysis (c) of cardiac TLR5 expression in WT mice at the
Fig. 2. The expression of TLR5 in cultured neonatal rat cardiomyocytes, H9c2 cardiomyocytes and endothelial cells during experimental cardiac remodelling. TLR5 mRNA expression in
neonatal rat cardiomyocytes was studied; no signiﬁcant change was observed upon stimulation with Ang II (1 μM for 24 h) or TGF-β1 (10 ng/ml for 1 day and 3 days) (a,b). TLR5 protein
expression inH9c2 cardiomyocyteswas studied; no signiﬁcant changewas observedupon stimulationwith Ang II (1 μMfor 24h) (c–d). Both themRNA (e) and protein expression of TLR5
(f,g) in HUVEC-12 cells were enhanced upon stimulation with TGF-β1 (10 ng/ml for 3 days). The H9c2 cells were transfected with Ad-TLR5shRNA (h), *P b 0.05 vs control. The degree of
cardiomyocyte hypertrophy was examined by RT-PCR (i) and α-actinin immunoﬂuorescence (j–k) (n = 3); *P b 0.05 vs control.
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operation (Fig. 4a,b).
To further elucidate the role of TLR5 in collagen synthesis during pres-
sure overload, the tissue mRNA expression levels of collagen Iα, collagen
IIIα, ﬁbronectin, connective tissue growth factor (CTGF), vimentin, α-
SMA, TGF-β1, and ﬁbroblast-speciﬁc protein 1 (FSP1), all of which are re-
sponsible for the development of cardiac ﬁbrosis, were examined.
8 weeks after AB, our data demonstrated that the levels of all of these in-
dicators were decreased in the TLR5-deﬁcient mice (Fig. 4c–j); these data
suggested that TLR5 deﬁciency attenuates cardiac ﬁbrosis.3.5. TLR5 deﬁciency decreases cytokine and macrophage inﬁltration
Pro-inﬂammatory cytokines (IL-1, IL-6, and TNF-α), which are pri-
marily produced by activated monocytes andmacrophages, play an im-
portant role in the pathogenesis of cardiac remodelling. To investigate
the mechanism underlying the decreased ﬁbrosis observed in the
TLR5 KO mice, we assessed myocardial pro-inﬂammatory cytokine
mRNA expression and macrophage inﬁltration. The sham-operated
mice exhibited a low level of IL-1, IL-6 and TNF-αmRNA expression; im-
munoﬂuorescence assays conﬁrmed that the extent of macrophage
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levels of IL-1, IL-6 and TNF-α in the WT mice were increased
1 week after AB, peaked 2 weeks after AB, and then gradually de-
creased. 8 weeks after AB, a signiﬁcantly higher pro-inﬂammatory
cytokine expression was observed in the AB group than in the
sham-operated group (Fig. 5a). Alternatively, in the TLR5-deﬁcient
group, the levels of the pro-inﬂammatory cytokine (IL-1, IL-6, and
TNF-α) and MIP-2 mRNA expression were signiﬁcantly lower thanFig. 3. The effects of TLR5 on cardiac dysfunction. Statistical analysis of the HW/BW ratio, the LW/B
HEandWGAstaining of the shamandAB-treatedmice at 8weeks post-surgery (e); Representative
8). The transcriptional expression of ANP, BNP,β-MHC, andα-MHC induced by ABwas determinethose in theWT group (Fig. 5b–e); immunoﬂuorescence assays dem-
onstrated that macrophage inﬁltration was also lower in the TLR5-
deﬁcient group (Fig. 5f). The activity levels of these cells appeared
to be increased in the AB-treated WT mice, and this ﬁnding was sup-
ported by the increased mRNA expression of MPO, TREM-1 and its
ITAM-containing adaptor DAP12 in the myocardium; however, in
the AB-treated TLR5-deﬁcient group, this phenomenon was signiﬁ-
cantly reversed (Fig. 5g–i).Wratio, the HW/TL ratio and the CSA of the indicated groups (a–d). Gross heart imaging and
M-mode images (f) and echocardiography results (g) 8weeks after AB or shamsurgery (n=
d via RT-PCR analysis (n=6) (h–k). *P b 0.05 vsWT/sham. #P b 0.05 vsWT/AB after surgery.
Fig. 3 (continued).
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EndMT is an important contributor to cardiac ﬁbrosis during
chronic pressure overload. Therefore, we investigated whether
TLR5 deﬁciency attenuates cardiac ﬁbrosis via the inhibition of the
EndMT. 1 week after AB, signiﬁcant upregulation of CD31 and vascu-
lar endothelial growth factor (VEGF) mRNA was detected in the
pressure overload-treated hearts; their levels gradually increased,
peaked 4 weeks after AB, and then decreased 8 weeks after AB. We
further found that the CD31 mRNA expression levels positively cor-
related with the VEGF mRNA expression levels in the pressure
overload-treated hearts (Fig. 6a–c). 8 weeks after AB, WB demon-
strated that the myocardial specimens from TLR5-deﬁcient mice ex-
hibited signiﬁcantly higher levels of CD31 and signiﬁcantly lower
levels of α-SMA and vimentin than those from the WT mice(Fig. 6d,e). These ﬁndings were conﬁrmed via the co-localization of
CD31 with α-SMA and with collagen III (Fig. 6f,g). These results
strongly suggest that the myocardial samples from the AB-induced
TLR5-deﬁcient mice exhibited decreased induction of the EndMT
compared with the WT mice.
To further elucidate the effect of TLR5 on the EndMT during pressure
overload, we examined certain signalling pathways and transcription fac-
tors known to play an important role in the EndMT. Various studies have
explored the roles of TGF-β1 and activated Smads in the EndMT, revealing
that the increased phosphorylation of Smad2 or Smad3 with Smad4 in-
duces the EndMT. Our quantitative WB analysis appeared to indicate
that both the p-Smad2 and p-Smad3 expression levels were decreased
in the AB-induced TLR5-deﬁcient mice compared with the WT mice
(Fig. 6h,i). Our results also indicated that the expression levels of several
transcription factors that play an important role in the EndMT, including
Fig. 4. TLR5 deﬁciency attenuates the ﬁbrotic response induced by pressure overload. Histological sections of the LV were stained for PSR in the indicated groups (a). The ﬁbrotic areas in
the histological sections were quantiﬁed using an image-analyzing system (b); the mRNA expression levels of collagen Iα, collagen IIIα, ﬁbronectin, CTGF, vimentin,α-SMA, TGF-β1 and
FSP-1 in the myocardium were determined in the indicated groups via RT-PCR analysis (c–j). *P b 0.05 vs WT/sham. #P b 0.05 vs WT/AB after surgery.
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deﬁcient mice (Fig. 6j–n).
3.7. TLR5 overexpression in the HUVEC-12 cells promoted the EndMT in re-
sponse to stimulation with TGF-β1
To conﬁrm the role of TLR5 in the EndMT, we performed gain-of-
function assays using HUVEC-12 cells. Cultured HUVEC-12 cells
transfected with Ad-TLR5 (TLR5 overexpression was conﬁrmed via WB)
(Fig. 7a,b) were treated with TGF-β1 (10 ng/ml) for 3 consecutive days;
the EndMT response in the HUVEC-12 cells was evaluated by measuring
endothelial and mesenchymal marker expressions. In the basal
medium-incubated cultures, the HUVEC-12 cells arrayed into a
cobblestone-like structure and gradually transitioned to a fusiform struc-
ture upon stimulation with TGF-β1 for 3 days; this phenotype wasenhanced in the HUVEC-12 cells transfected with Ad-TLR5 that were
stimulated with TGF-β1. However, no effect on cell structure was ob-
served when the cells were only transfected with Ad-TLR5 (Fig. 7c).
The WB results demonstrated that the HUVEC-12 cells stimulated
with TGF-β1 exhibited signiﬁcantly lower levels of CD31 and signiﬁcantly
higher levels of α-SMA and vimentin than the control cells.
This phenotype was enhanced in the HUVEC-12 cells transfected with
Ad-TLR5 thatwere stimulatedwith TGF-β1, as the level of CD31 level fur-
ther decreased and the levels of α-SMA and vimentin further increased
compared with the non-transfected HUVEC-12 cells treated with TGF-
β1. No effect on the expression of these cell markers was detected in
the cells that were only transfected with Ad-TLR5. These ﬁndings were
conﬁrmed by the co-localization of CD31 with α-SMA (Fig. 7d–f).
To determine the capacity of the transitioned endothelial cells tomi-
grate to surrounding tissue, an in vitro scratch assaywas performed.Our
Fig. 5. Decreased pro-inﬂammatory cytokine expression and macrophage inﬁltration in the AB-treated TLR5-deﬁcient hearts. The mRNA expression levels of IL-1, IL-6 and TNF-αwere
measured at the indicated time points following AB (n = 6) (a). The mRNA expression levels of IL-1, IL-6, TNF-α and MIP-2 in cardiac homogenates from the 4 groups of mice 8 weeks
after AB or sham surgery (n = 6) (b–e). Immunohistochemical studies revealed the extent of the recruitment of CD68-positive mononuclear cells in the 4 groups of mice 8 weeks
after AB or sham surgery (n = 6) (f); The mRNA expression levels of MPO, TREM-1 and its ITAM-containing adaptor DAP12 in cardiac homogenates from the 4 groups of mice
8 weeks after AB or sham surgery (n = 6) (g–i). *P b 0.05 vs WT/sham. #P b 0.05 vs WT/AB after AB.
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migrated faster than the basal medium-treated cells (data not shown).
The HUVEC-12 cells that were transfected with Ad-TLR5 and stimulated
with TGF-β1 migrated even faster than the cells that were only treated
with TGF-β1 (Fig. 7g).
4. Discussion
The deﬁciency of TLR5 in this model exerted no basal effects but at-
tenuated the cardiac ﬁbrosis, hypertrophy and dysfunction induced by
pressure overload. In our study, we found that vascular TLR5 mRNA ex-
pression was low but was increased following stimulation with the
stimulus TGF-β1, which modulates intracellular signalling pathways
and promotes vascular remodelling.We also found that AB-induced en-
dothelial TLR5 activation enhances the development of cardiac ﬁbrosis
independent of cardiomyocyte hypertrophy and results in LV dysfunc-
tion. TLR5 deﬁciency also ameliorates myocardial pro-inﬂammatory cy-
tokine expression andmacrophage inﬁltration, and inhibits the EndMT,all of which contribute to the development of cardiac hypertrophy and
ﬁbrosis. All of the above data suggest that TLR5 triggers and enhances
the effects of inﬂammatory mediators and promotes the EndMT,
which may be an important mechanism underlying the increases in
cardiac ﬁbrosis, hypertrophy and LV dysfunction during pressure
overload.4.1. The role of TLR5 in the EndMT during pressure overload
Weused three cell types tomeasure TLR5 expression in the presence
of different stimuli during pressure overload. We found that only the
treatment of HUVEC-12 with 10 ng/ml TGF-β1 for 3 consecutive days
upregulated TLR5 expression. However, no change in TLR5 expression
was detected in H9c2 cardiomyoblasts or neonatal rat cardiomyocytes
following Ang II treatment for 24 h. Therefore, we speculated that
TLR5 modulates cardiac remodelling via the promotion of vascular re-
modelling and, likely, the EndMT.
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Fig. 7. The overexpression of the TLR5 gene promoted the EndMT inHUVEC-12 cells. The HUVEC-12 cells were transfectedwith Ad-TLR5 (a,b); *P b 0.05 vs control. The structural changes
in the cells were examined under an inverted microscope (c). Representative WBs (d) and quantitative WB results (e) showing the mean levels of CD31, α-SMA and vimentin in the
HUVEC-12 cells following stimulation with TGF-β1 (n = 3); *P b 0.05 vs control; #P b 0.05 vs TGF-β1 alone. HUVEC-12 cells were co-immunostained for CD31 (green) and α-SMA
(red) and were imaged via ﬂuorescence microscopy; the results shown are representative of 3 repeated experiments (f). In vitro scratch assay. The cells were stained with crystal violet.
The overexpression of TLR5 promoted the migration of endothelial cells upon stimulation with TGF-β1; the experiments were repeated 3 times (g).
Fig. 6.DecreasedEndMT inAB-inducedTLR5-deﬁcient hearts. ThemRNAexpressionof CD31 andVEGF at the indicated timepoints after AB (n=6) (a,b), and the Pearson correlation coefﬁcient
for the two indicators (n=6) (c). RepresentativeWBs (d) and quantitativeWB analysis results (e) showing themean CD31,α-SMA and vimentin levels in the cardiac homogenates from the 4
groups of mice 8weeks after AB or sham surgery (n= 3). Myocardial sections were co-immunostained for CD31 (green)/α-SMA (red) or CD31 (green)/collagen III (red) andwere imaged via
ﬂuorescencemicroscopy (f, g). RepresentativeWBs (h) andquantitativeWBanalysis results (i) of phosphorylated and total Smad2 andSmad3expression in cardiac homogenates from themice
in the indicated groups (n = 3). The mRNA expression levels of snail1, snail2, twist1, twist2, and N-cadherin in the myocardium were determined in the indicated groups via Real Time-PCR
analysis (j–n). *P b 0.05 vs WT/sham. #P b 0.05 vs WT/AB after surgery.
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2466 Y. Liu et al. / Biochimica et Biophysica Acta 1852 (2015) 2456–2466Vascular TLR5 expression is low under normal circumstances but is
increased in response to stimuli such as pressure overload, as conﬁrmed
in our experiments. We found that the EndMT was signiﬁcantly de-
creased in the TLR5-deﬁcient group compared with the WT group
8weeks after AB. Additionally, the gene expression levels and the activ-
ity of signalling pathways that play an important role in promoting the
EndMT were decreased in the TLR5-deﬁcient group. Additional deﬁni-
tive evidence that endothelial TLR5 promotes the EndMT was obtained
using cultured HUVEC-12 cells, as TLR5 overexpression enhanced the
EndMT in response to TGF-β1 stimulation. These results strongly sug-
gest that TLR5 expression within the endothelium plays an important
role in promoting the EndMT, leading to cardiac ﬁbrosis, in response
to chronic pressure overload.
In this study,we observed that both CD31 andVEGFmRNAgradually
increased after AB, peaked at 4 weeks, and then signiﬁcantly decreased
at 8 weeks. It appeared that both the density of the vasculature and the
levels of vascular growth factorswere decreased at 8weeks. Becausewe
speculated that this was the time point at whichmany endothelial cells
lose their surface markers and transform into ﬁbroblasts, we selected
8 weeks after AB to study the EndMT. This speculation was conﬁrmed
by our results.
4.2. The role of TLR5 in the pro-inﬂammatory cytokine expression andmac-
rophage inﬁltration
The pro-inﬂammatory cytokines which were induced by pressure
overload are highly pleiotropic, not only cause myocardial hypertrophy
but also regulate the ﬁbrotic process via several distinct pathways [9,
16–18]. In our experiments, the levels of the pro-inﬂammatory factors
IL-1, IL-6 and TNF-α were signiﬁcantly increased after AB and peaked
2 weeks after AB, followed by decreased levels thereafter. 8 weeks
after AB, the levels of these inﬂammatory mediators remained signiﬁ-
cantly elevated in the AB-treated WT group compared with the sham-
operated group. Pro-inﬂammatory cytokines are primarily produced
by activated monocytes/macrophages [19]. Therefore, we measured
MIP-2 (a chemokine that attracts polymorphonuclear cells particularly
monocytes andmacrophages) [20] and CD68 [21] (macrophage surface
marker). We found moderate recruitment of mononuclear cells in the
WT group after AB. The degree of activation of these inﬁltrating cells ap-
peared to be increased because of the activation and the increases in
cardiac MPO, TREM-1 and its receptor DAP-12, suggesting that the car-
diac inﬂammatory phenotype triggered by AB primarily results from the
activation of BM. However, in the TLR5-deﬁcient group subjected to AB,
the levels of both the pro-inﬂammatory cytokines and themacrophages
were reduced compared with the correspondingWT group. It appeared
that the activation of BM was also signiﬁcantly decreased in the TLR5-
deﬁcient group; it also indicated that, TLR5 expression bymacrophages
is a powerful mediator of cardiac hypertrophy and ﬁbrosis through the
upregulation of pro-inﬂammatory paracrine signalling.
In our study, we used a mouse model with global TLR5 deﬁciency. A
portion of the favourable effect of TLR5 deﬁciency on the consequences
of pressure overloadmay have occurred as a result of the loss of TLR5 in
non-myocardial cell types or in organs such as the liver and the kidneys.
Therefore, the use of an endothelium-targeted deﬁciency model should
be undertaken to conﬁrm that the role of TLR5 is independent of the
other changes that are secondary to pressure overload that occur during
cardiac remodelling. Nevertheless, the current results obtained using
the global TLR5-deﬁcient mice may be predictive of potential side ef-
fects that occur secondary to TLR5 deﬁciency in the endothelium.Furthermore, to determine the extent that pro-inﬂammatory cyto-
kines inﬂuence the development of myocardial ﬁbrosis, we should per-
form BM transplantation in future studies to create chimeric mice
carrying different TLR5 genotypes between the BM and resident tissue
cells, as this confound was a limitation of this study.Transparency document
The Transparency document associated with this article can be
found, in the online version.References
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